Hitting the Right Spot: Advances in the Treatment of NSCLC with Uncommon EGFR Mutations
Format: Journal Supplement
Credit(s): 1.00 (60 min)
Release Date: Dec 06, 2021
Expiration Date: Dec 06, 2022
CME / AMA PRA Category 1 Credit™
MOC / ABIM MOC Part 2 Credit
While the majority of patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) carry “common” EGFR mutations that are easily targeted with standard TKIs, up to 20% of these patients have uncommon mutations that are more difficult to treat. Uncommon EGFR mutations, including the G719X, S768I, and L861Q point mutations and exon 20 insertions, are more difficult to treat, have fewer treatment options, and are associated with a poorer prognosis. In recent years, novel treatments with efficacy against uncommon EGFR mutations have emerged. The EGFR TKI afatinib has been specifically approved for the treatment of G719X, S768I, and L861Q point mutations, and two novel EGFR targeted therapies—amivantamab and mobocertinib—have recently been granted Breakthrough Therapy Designation by the FDA for the efficacy against exon 20 insertions.
This activity, Hitting the Right Spot: Advances in the Treatment of NSCLC with Uncommon EGFR Mutations, will provide oncology clinicians with information on the biology and challenges associated with uncommon EGFR mutations, the latest guidance on identifying patients with these mutations, and safety and efficacy data for novel treatment options for patients who carry these mutations.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
In collaboration with
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Takeda Oncology.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.